Australia consumer sentiment index dips 0.7% in Jan
SYDNEY (Reuters) – Australian consumer sentiment dipped for a second month in January as financial stress dominated at the start of the new year, a survey showed on Tuesday, suggesting…
Investing
5025 posts
Six EU countries call for lowering of G7 price cap on Russian oil
BRUSSELS (Reuters) -Six European Union countries on Monday called on the European Commission to lower the $60 per barrel price cap put on Russian oil by G7 countries, arguing it…
Morning Bid: No let up from dollar, US yield squeeze
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. A sea of red across most equity markets and no end in sight to the rise…
US Fed bank boards more diverse this year than last
(Reuters) – The boards of directors of the Federal Reserve’s 12 regional banks have grown more diverse by gender and race in 2025, data released by the U.S. central bank…
Markets can weather a ‘no landing’ scenario, Deutsche Bank says
Investing.com — Markets are struggling in the wake of a surging Treasury yields on fresh fears disinflation could be stalling even as growth remains solid, but Deutsche Bank (ETR:DBKGn) believes…
Top House Republican says should be conditions on California wildfire aid
WASHINGTON (Reuters) – Republican U.S. House Speaker Mike Johnson said on Monday that Congress should place conditions on aid to Los Angeles communities devastated by wildfires, alleging that state and…
HCLTech misses Q3 revenue targets, narrows growth forecast amid tech spending slowdown
India’s third-largest software company, HCLTech, reported third-quarter results on Monday that fell short of analysts’ revenue expectations, as clients reduced their discretionary technology spending. The company also narrowed its revenue…
Will banks deliver? Earnings report to reveal true picture of US lending sector
Investors’ buoyant outlook on US banks, which propelled stocks higher at the close of 2024, is about to face a rigorous test as earnings season kicks off this week. The…
Moderna stock takes a 20% hit: here’s why
Moderna Inc (NASDAQ: MRNA) tanked as much as 20% in premarket on Monday after lowering its full-year sales guidance by about $1.0 billion. The biotech giant cited headwinds as it…
Gilead’s new HIV prevention drug lenacapavir will ‘change the face of HIV,’ says CEO Daniel O’Day
Gilead Sciences Inc (NASDAQ: GILD) is strongly positioned to “change the face of HIV” in 2025, according to its chairman and chief executive Daniel O’Day. He dubbed lenacapavir – the…